AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06370975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ringer's lactated solution
Description: the patients received ringer's lactated solution at the rate of 20 ml/kg for 30 minute. the intervention period for the study ran for the first hour of treatment, and serial monitoring and lab tests were done during this period, measurement lactate levels will done at 0, 30, 60 mins and 24 hour, the ABG parameters were recorded 30 and 60 min after the completion of the calculated dose infused with fluids and serial monitoring of vital parameters was done at 0, 15, 30, and 60 mins. The lactate clearance was calculated as follows:~-hour lactate clearance (%) = (0-hour lactate - 1-hour lactate) / 0-hour lactate × 100
Study NCT06370975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.9% Normal saline
Description: the patients received 0.9% Ns at the rate of 20 ml/kg for 30 minute. the intervention period for the study ran for the first hour of treatment, and serial monitoring and lab tests were done during this period, measurement lactate levels will done at 0, 30, 60 mins and 24 hour, the ABG parameters were recorded 30 and 60 min after the completion of the calculated dose infused with fluids and serial monitoring of vital parameters was done at 0, 15, 30, and 60 mins. The lactate clearance was calculated as follows:~-hour lactate clearance (%) = (0-hour lactate - 1-hour lactate) / 0-hour lactate × 100
Study NCT04120779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The EMPOWER-SUSTAIN e-Health Self-Management Intervention
Description: Multifaceted chronic disease management strategies involving web-based self-management intervention mobile apps based on chronic care model and persuasive technology theory to improve patient activation and self-management behaviours among patients with metabolic syndrome.
Study NCT05573815 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BT-M01
Description: Clinical decision support system for detecting brain metastasis
Study NCT04046861 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: ascorbic acid,
Description: The vitamin C group will get high dose of intravenous vitamin C (ascorbic acid) before starting cardiopulmonary bypass, before removing aortic clamp and every 8 hours thereafter for additionaly 24 hours
Study NCT04046861 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (saline)
Description: The placebo group will get saline before starting cardiopulmonary bypass, before removing aortic clamp and every 8 hours thereafter for additionaly 24 hours
Study NCT04023708 — intervention group
Intervention type: DRUG
Intervention: CYD-TDV Dengue Vaccine
Description: Pharmaceutical form:Solution Route of administration: Intramuscular
Study NCT06736860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid (TXA) injection
Description: All enrolled patients with acute trauma were given 1 g tranexamic acid (TXA) within 3 h after trauma, which was infused intravenously within 10 min, and randomized into groups. After admission, the first laboratory examination was conducted for both groups. The 1+1 control group continued to infuse 1g TXA within 8 h.
Study NCT06736860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) injection
Description: All enrolled patients with acute trauma were given 1 g tranexamic acid (TXA) within 3 h after trauma, which was infused intravenously within 10 min, and randomized into groups. After admission, the first laboratory examination was conducted for both groups. the 1+x study group was subjected to thromboelastography (TEG) without TXA for the time being, and the coagulation and fibrinolytic status of the patients was judged according to the results of TEG (LY30, EPL value), and the patients diagnosed with hyperfibrinolysis continued to be infused with 1g TXA, and the patients diagnosed with normal or reduced fibrinolysis were not infused with TXA. TEG was rechecked after 4 h, and the decision of whether to use TXA was based on the TEG results.
Study NCT06740565 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thoracic endovascular aortic repair
Description: stent-graft implanted to seal the proximal entry tear of type B aortic dissection
Study NCT06740565 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thoracic endovascular aortic repair
Description: stent-graft implanted to seal the proximal entry tear of type B aortic dissection
Study NCT06737926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensorimotor Training Exercise
Description: Participants will perform sensorimotor training exercises designed to improve balance, reduce pain intensity, and enhance functional exercise capacity. The program will include progressive exercises focusing on proprioception, neuromuscular coordination, and functional mobility. Sessions will be conducted thrice weekly over 12 weeks, supervised by a physiotherapist.
Study NCT04718753 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful breathing intervention
Description: Mindful breathing intervention audio, which is used in mindfulness-based interventions, will be sent to the participants once per day.
Study NCT05307107 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SHINE
Description: Intervention group will use a 8-workweeks the digital Smart Break SHINE program with workplace support (encouragement and time-support) including daily 3 minutes break exercises twice a day; 1) physical exercise - break and 2) body/mind breathing exercise - break earning stars for exercise completed. The program includes weekly self-reflective task of individual well-being during working hours with weekly changing theme (avoiding sitting time, nature benefits, relaxation exercises, increasing physical activity in workplace etc.) earning diamonds for every weekly task completed. Participants self-monitors their weekly individual resources levels asked in every Thursday (1-5, 1= very poor. 5= very good). Program includes e-mail remainders set by participant themselves for suitable time frame These individual well-being actions takes approximately 15 minutes/workday. Control group will receive this program after this study (waitlist protocol).
Study NCT06737926 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Exercise Therapy
Description: Participants will undergo conventional exercise therapy, including stretching, strengthening, and aerobic exercises, based on standard physiotherapy protocols. The therapy aims to maintain joint mobility, reduce stiffness, and improve general physical fitness. Sessions will be conducted thrice weekly over 12 weeks, supervised by a physiotherapist.
Study NCT06738524 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fighting with Digital Addiction
Description: The purpose of this training is to raise awareness among young people about the signs, causes and consequences of addictive use of technology and how to avoid excessive use of technology and technology addiction.
Study NCT06736613 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cerebral Spinal Fluid ctDNA
Description: MSK's Diagnostic Molecular Pathology core has developed and validated a CSF ctDNA assay which has been approved by New York State Department of Health as of 2019
Study NCT06740721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: False Lumen Embolization System, IMPEDE-FX RapidFill
Description: Embolization of the false lumen of an aortic dissection
Study NCT06741202 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Men's MST Group
Description: see above
Study NCT06741202 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Present-Centered Group Therapy
Description: see above
Study NCT05893134 — intervention group
Intervention type: OTHER
Intervention: Risk Assessment
Description: A probabilistic risk model will be generated based on the variables of different natures used and maps will be built to identify the areas of greatest risk for dengue transmission in the study area
Study NCT06362785 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: The intervention group will engage in immersive virtual reality sessions with interactive activities involving functional movements of the spine and limbs in a virtual environment using Meta Quest 3 goggles. The intervention will last for 6 weeks, comprising a total of 12 sessions, with a maximum duration of 30 minutes of virtual reality and 15 minutes of rest (45 minutes in total per session).
Study NCT04955925 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound examination of the optic nerve sheath diameter
Description: The optic nerve sheath diameter is examined using ultrasonography.
Study NCT06739551 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate (drug)
Description: oral methotrexate 10 mg per week for 12 weeks
Study NCT06739551 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acitretin
Description: oral acitretin 50 mg once daily for 12 weeks
Study NCT06740591 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HD-tDCS
Description: The HD-tDCS stimulation was applied for 20 minutes, 5 times a week, for a total of 10 sessions.
Study NCT05319704 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Test of effort on cycle on concentric or excentric mode
Description: participants may receive 4 interventions sequentially during the protocol
Study NCT05319704 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Test of effort on cycle on concentric or excentric mode
Description: participants may receive 4 interventions sequentially during the protocol
Study NCT06740591 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham High-Definition Transcranial Direct Current Stimulation(sham HD-tDCS)
Description: The Sham HD-tDCS stimulation was applied for 20 minutes, 5 times a week, for a total of 10 sessions.
Study NCT06739720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LingZhi capsule
Description: Lingzhi-containg capsules (CP003) is a Chinese Medicine nutritional supplement manufactured by Chinese Pharm CO LTD containing: wild red ganoderma extract, ganoderma spore powder (99.9% broken wall), β-nicotinamide mononucleotide (NMN), wild yellow ganoderma extract, wild green ganoderma extract, wild purple ganoderma extract, wild white ganoderma extract, wild black sesame extract
Study NCT06738095 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: daily low-level red-light
Description: Daily low-level red-light is a kind of myopia intervention. Red-light typically using 650-nm wave of length. The treatment duration last 3 minutes each time, every day children were anticipated to use two times, at home.
Study NCT06740370 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE procedure was a 2.8-F microcatheter was super-selectively inserted into the tumor feeding artery using the coaxial technique. Then a combination of lipiodol (5-15 ml), lobaplatin (30-50 mg), and Pirarubicin (30-50 mg) was infused into each tumor. We defined technical success as complete embolization of the tumor-feeding artery resulting in no tumor staining observed by angiogram at the end of procedure.
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-5041 tablets
Description: HRS-5041 tablets
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate tablets（II）
Description: Abiraterone Acetate tablets（II）
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone Acetate tablets
Description: Prednisone Acetate tablets
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel Injection
Description: Docetaxel Injection
Study NCT05319704 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Kinetics on concentric or excentric mode during test of effort
Description: participants may receive 4 interventions sequentially during the protocol
Study NCT05319704 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinetics on concentric or excentric mode during test of effort
Description: participants may receive 4 interventions sequentially during the protocol
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1167 tablets
Description: HRS-1167 tablets
Study NCT06568094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR2554 tablets
Description: SHR2554 tablets
Study NCT04925570 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: W-SUDs
Description: Woebot (W-SUDs) is an automated conversational agent, available through a smartphone application, that delivers evidence-based psychotherapeutics, empathy, and emotional health psychoeducation.
Study NCT04925570 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Digitally-delivered Psychoeducation
Description: A form of psychoeducation for those seeking treatment for their alcohol and/or substance use concern. Psychoeducation is commonly provided for those with substance use. Psychoeducation in substance use is intended to increase the users' knowledge of their substances of use, and effects on the body, behaviors, and consequences. The recipient of psychoeducation is expected to increase their own awareness of their substance use and ideally incorporate this newfound knowledge when making changes to their substance use. The information provided in this group are from factsheets found on NIAAA, NIDA, and CDC web pages.
Study NCT05142241 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05142241 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05142241 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05142241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talazoparib
Description: Given PO
Study NCT05142241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given PO
Study NCT06585306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: jaw lift, increasing oxygen flow, mask ventilation, intubation
Description: When patients develop hypoxemia, the above interventions are sequentially employed to improve their oxygenation status.
Study NCT05116969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTX-35
Description: PTX-35 is a humanized, affinity matured, IgG2 monoclonal antibody
Study NCT04954677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-box
Description: Automatic quality-control system（AI-box）could real-time measure endoscopic inspection completeness, evaluate gastric cleanliness.
Study NCT05021926 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DKL crosslinked sodium hyaluronate 26
Description: is injected into the midface on Day 1. The volume of injection will not exceed 2 mL per side. If applicable, a touch-up of DKL crosslinked sodium hyaluronate 26 will be injected on Day 30; the volume of injection will not exceed 1 mL per side.
Study NCT05021926 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Juvéderm Voluma™ with lidocaine (Allergan, Inc)
Description: is injected into the midface on Day 1. The volume of injection will not exceed 2 mL per side. If applicable, a touch-up of Juvéderm Voluma™ will be injected on Day 30; the volume of injection will not exceed 1 mL per side.
Study NCT04835363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Occupational Therapy intervention
Description: four-week OT intervention program with the support of the main caregiver in patients who have suffered a stroke with the aim of improving the functional result and facilitating the return home by providing knowledge to the caregiver about specific care and neurorehabilitation.
Study NCT06467019 — intervention group
Intervention type: OTHER
Intervention: Informative Session
Description: The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.
Study NCT06237491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-LNC1003 Injection group 1
Description: The treatment regimen will consist of a single dose 30 mCi intravenous administration of 177Lu-LNC1004 Injection per 6-week cycle, for a total of 2 cycles, the dose per cycle will be fixed.
Study NCT06237491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-LNC1003 Injection group 2
Description: The treatment regimen will consist of a single dose 50 mCi intravenous administration of 177Lu-LNC1004 Injection per 6-week cycle, for a total of 2 cycles, the dose per cycle will be fixed.
Study NCT06237491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-LNC1003 Injection group 3
Description: The treatment regimen will consist of a single dose 70 mCi intravenous administration of 177Lu-LNC1004 Injection per 6-week cycle, for a total of 2 cycles, the dose per cycle will be fixed.
Study NCT06057857 — intervention group
Intervention type: OTHER
Intervention: conventional oral examination
Description: conventional oral examination
Study NCT05086835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Working Memory Task
Description: A smartphone-based visual-spatial working memory task that will be optimized in the Stage 1A phase of this study.
Study NCT05086835 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Visual Search Task
Description: A smartphone-based visual search task that will be optimized in the Stage 1A phase of this study.
Study NCT05369884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WPQW granule
Description: WPQW granule, 2 sachets / time, 3 times / day.
Study NCT05369884 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: WPQW granule simulant
Description: WPQW granule simulant, 2 sachets / time, 3 times / day.
Study NCT06628102 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Chest CT Scan
Description: Chest CT Scan
Study NCT06732674 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: A home monitoring strategy with event driven management
Description: Bi-weekly home monitoring with forced vital capacity (FVC), patient reported outcome measures (PROMs), at-home measures of blood oxygen levels (SpO2) during 1-minute-sit-to-stand test (1MSTS) and temperature with algorithm based risk evaluation of deterioration and infection and consecutive event driven management
Study NCT05221229 — intervention group
Intervention type: DRUG
Intervention: Liraglutide plus upstream risk factors modification advice and consultation
Description: Patients will be on treatment with daily injections of Liraglutide for a total of 65 weeks. During initial consultation for AF ablation, patients' BMI, risk factors status and baseline blood tests were performed and reviewed. Then the patients were discussed and encouraged to achieve optimal goal of risk factors modifications by non pharmacological and pharmacological measures.
Study NCT06570655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huperzine A injection
Description: intramuscular
Study NCT06570655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huperzine A injection
Description: intravenous bolus
Study NCT05415501 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sentence training
Description: Participants will be trained to read, make, and recall sentences during each session.
Study NCT03998605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Abuse Prevention Program
Description: The abuse prevention program will be comprised of nine shared learning modules for the individual with Intellectual Disabilities (ID) and a care provider. Each shared module will contain an action step in the Individual Response Plan and will include video, guided practice and workbook activities to equip persons with ID with a range of judgment, decision-making skills and the efficacy needed for identifying, rejecting, and reporting abuse.
Study NCT03998605 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Condition
Description: The control group will receive worksheets from the ESCAPE-NOW curriculum.
Study NCT06234358 — intervention group
Intervention type: DEVICE
Intervention: osteosynthesis
Description: calcaneus osteosynthesis is a surgical fixation of a displaced fracture of the calcaneous bone. The surgery is performed under general or regional anesthesia. A scar is made on the lateral side of the ankle below the lateral malleolus. The bone fragments are repositioned as anatomically as possible. They are fixed by a percutaneous nailing fastener.
Study NCT04760704 — intervention group
Intervention type: BIOLOGICAL
Intervention: Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration
Description: Specific T cells and specific antibodies assessment
Study NCT04990739 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MTB-9655
Description: MTB-9655 is an orally available investigational product that is highly potent as it exhibits selectivity as an ACSS2 inhibitor when tested against a panel of related enzymes. MTB-9655 is formulated as a powder blend in a hydroxypropyl methylcellulose (HPMC) capsule and is presented as 25 mg and 100 mg strengths for oral administration.~Patients will receive MTB-9655, by mouth daily in 21-day treatment cycles,either 1 hour before mealtime or 2 hours after mealtime.
Study NCT05772364 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Loading of low-calcium water first, then high-calcium water
Description: All cohort subjects are asked to consume water with less than 5 mg/L of calcium first, then are asked to consume water with at least 400 mg/L of calcium